“『 YEOTOP3.COM 』 여탑애오개오피Ⅵ애오개건마✼애오개출장ⅱ애오개립카페☌애오개오피❊애오개키스방ぷ애오개스파”的搜索结果，显示 351-360 项，共有 11491 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to determine the safety and tolerability of and to define the maximum tolerated dose (MTD) and Recommended Phase 2 ...

2. 心血管医学- 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to develop a registry of molecularly confirmed Familial Hypercholesterolemia (FH) cases in conjunction with the ...

3. 神经科- 临床试验- 妙佑医疗国际

   The purpose of this study is to determine the maximum tolerated dose (MTD) and/or the recommended Phase 2 dose (RP2D) of WSD0922-FU in subjects with recurrent ...

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Establish a prospective database of all patients with peritoneal surface malignancies seen by Dr. Travis Grotz at the Mayo Clinic, Rochester. Design and ...

5. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Albert Lea, Minn., Rochester, Minn., Jacksonville, Fla. The puporse of this trial is to compare less intense hormone therapy and radiation therapy to usual ...

6. 神经科- 临床试验- 妙佑医疗国际

   The purpose of phase 2 of this trial is to evaluate the effectiveness of sequentially administering temozolomide and selinexor in recurrent glioblastoma as ...

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This phase II trial studies the effect of pembrolizumab, dabrafenib, and trametinib before surgery in treating patients with BRAF V600E-mutated anaplastic ...

8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The aims of this study are to investigate the presence of tumor cells after filtration of autologous blood products by intraoperative cell saver, ...

9. 神经科- 临床试验- 妙佑医疗国际

   ... 6-month Progression Free Survival (PFS) rate (Phase II). A Study of Pyridostigmine in Postural Tachycardia Syndrome. Rochester, Minn. This is a 3-day study ...

10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    Rochester, Minn. This is a Phase 1b/2 open-label study to evaluate the safety/efficacy of MEDI-551 + MEDI0680 (AMP-514) ...